Prof. Hilal A. Lashuel is the Research Development and Innovation Advisor to the Chairperson of Qatar Foundation and Executive Director of RDI at the Chairperson’s Office. He also directs the Laboratory of Chemical Biology of Neurodegeneration at EPFL and is Founder and CEO of ND Biosciences SA. Prof. Lashuel received his B.Sc. in Chemistry from the City University of New York and completed his Ph.D. at Texas A&M University and the Scripps Research Institute. He held research positions at the Picower Institute, Harvard Medical School, and Brigham and Women’s Hospital. At EPFL since 2005, his research focuses on understanding protein misfolding in neurodegenerative diseases and developing therapies and diagnostics. He has served in leadership roles at Qatar Biomedical Research and Qatar Genome Project and advised on several national and international scientific committees. Prof. Lashuel has authored over 225 publications, holds nine patents, and has delivered over 250 invited lectures. His work has been widely recognized with awards, including the Kuwait Prize in Biological Sciences and the Takreem Foundation's Scientific Achievement Award. He is also a Young Global Leader of the World Economic Forum.